4.5 Review

α-Synuclein regulation of the dopaminergic transporter:: a possible role in the pathogenesis of Parkinson's disease

Journal

FEBS LETTERS
Volume 565, Issue 1-3, Pages 1-5

Publisher

WILEY
DOI: 10.1016/j.febslet.2004.03.063

Keywords

dopamine transporter; alpha-synuclein; Parkinson's disease; synucleinopathies; 1-methyl-4-phenyl-1 2,3,6-tetrahydropyrimidine; neurodegeneration; Lewy bodies

Funding

  1. NINDS NIH HHS [NS-34914, NS-45326] Funding Source: Medline

Ask authors/readers for more resources

Parkinson's disease (PD) is a slow progressive neurodegenerative disorder. Recent evidence suggests a central role for alpha-synuclein, a protein of unknown function, in the genesis of PD. The phenomenon of selective degeneration of dopaminergic neurons in PD may be linked to the potential toxicity of dopamine itself and aberrations in the processes which regulate dopamine content may underlie the pathogenesis of this disease. Here, we review a vital role of alpha-synuclein in the modulation of dopamine transporter (DAT) function, and describe how disruption of this modulatory process permits increased re-uptake of high levels of intracellular dopamine by DAT, causing profound neurotoxicity. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available